The latest news from a long-term study of calorie restriction in rhesus macaques shows better health, but no boost in lifespan, in monkeys who eat less.
Advertisement
The Scientist
Most Recent
Results from a Phase II trial for cardiovascular disease with an epigenetic target therapy show promise.
A human trial of a hepatitis C treatment is shut down after one of the participants died.
Another person has died from the rodent-borne disease after visiting Yosemite National Park.
Researchers consider the recent reappearance of West Nile virus in Texas and the efforts to control it.
Researchers show that blood spotted onto Guthrie cards, usually at birth, can be a high quality source of methylated DNA for long-term epigenetic studies.
A polar bear in a German zoo dies after contracting a virus normally found in zebras.
A former manager at Genentech claims the company bypassed ethical and clinical guidelines in order to rush a promising drug through clinical trials.
Patent expirations of one HIV drugs will make the disease cheaper—but also more cumbersome—to treat.
A strategy to transmit signals to retinal nerve cells may show promise as a step toward alternative retinal prosthesis design.
Follow The Scientist
Advertisement
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
